Privia Health Group (NASDAQ:PRVA) CFO Sells $680,185.00 in Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 24,734 shares of the company’s stock in a transaction that occurred on Thursday, July 2nd. The stock was sold at an average price of $27.50, for a total value of $680,185.00. Following the completion of the sale, the chief financial officer directly owned 186,728 shares of the company’s stock, valued at approximately $5,135,020. This represents a 11.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Mountcastle also recently made the following trade(s):

• On Tuesday, July 7th, David Mountcastle sold 600 shares of Privia Health Group stock. The stock was sold at an average price of $27.57, for a total transaction of $16,542.00.
• On Friday, June 26th, David Mountcastle sold 17,196 shares of Privia Health Group stock. The stock was sold at an average price of $25.18, for a total transaction of $432,995.28.
• On Monday, May 11th, David Mountcastle sold 3,385 shares of Privia Health Group stock. The stock was sold at an average price of $22.60, for a total transaction of $76,501.00.
• On Monday, May 4th, David Mountcastle sold 1,206 shares of Privia Health Group stock. The shares were sold at an average price of $25.00, for a total transaction of $30,150.00.
• On Friday, May 1st, David Mountcastle sold 7,179 shares of Privia Health Group stock. The shares were sold at an average price of $25.03, for a total transaction of $179,690.37.

Privia Health Group Stock Up 2.1%

Shares of NASDAQ:PRVA opened at $27.77 on Friday. The stock has a market cap of $3.50 billion, a PE ratio of 173.57, a PEG ratio of 2.15 and a beta of 0.83. The company’s fifty day moving average is $23.71 and its 200 day moving average is $23.11. Privia Health Group, Inc. has a 52 week low of $18.77 and a 52 week high of $27.81.

Institutional Investors Weigh In On Privia Health Group

A number of institutional investors have recently bought and sold shares of the business. Bayban purchased a new stake in Privia Health Group during the 4th quarter valued at approximately $26,000. Hantz Financial Services Inc. increased its holdings in shares of Privia Health Group by 456.2% in the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock worth $27,000 after purchasing an additional 926 shares during the last quarter. Global Retirement Partners LLC lifted its position in shares of Privia Health Group by 579.8% in the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company’s stock worth $38,000 after buying an additional 1,351 shares in the last quarter. Harbor Investment Advisory LLC bought a new position in Privia Health Group during the second quarter valued at approximately $69,000. Finally, Canada Pension Plan Investment Board boosted its stake in Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after buying an additional 1,200 shares during the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Weiss Ratings upgraded shares of Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 2nd. Barclays lowered their target price on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 26th. Evercore set a $26.00 price target on shares of Privia Health Group in a research report on Wednesday, April 8th. Canaccord Genuity Group cut their target price on Privia Health Group from $35.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, May 8th. Finally, Zacks Research downgraded shares of Privia Health Group from a “hold” rating to a “strong sell” rating in a research note on Tuesday. Eleven analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $31.15.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.